Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Xarelto
Pharma
Bayer's 'transition year' looms as Xarelto sales falter
As Xarelto generics continue to eat away at sales, Bayer's Nubeqa and Kerendia are picking up the slack.
Zoey Becker
Nov 12, 2024 3:03pm
J&J ushers in new 340B rebate policy for Stelara, Xarelto
Aug 26, 2024 11:23am
Bayer charts growth course amid Xarelto's ongoing sales descent
Aug 6, 2024 12:29pm
J&J, Bayer's Xarelto proves its worth across PAD patients
Nov 14, 2023 11:33am
ICER weighs in on Eliquis, Xarelto price negotiations at CMS
Oct 2, 2023 2:42pm
Bayer's new CEO Bill Anderson weighs structural change
Aug 8, 2023 11:15am
